Curcumin nanocapsules can directly reduce the levels of the proinflammatory cytokines IFN-γ and IL-17 and increase the levels of the anti-inflammatory cytokines TGF-β and IL-4 in patients with COVID-19 (256). This evidence concerns the gene IFNG and COVID-19.